Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,964 public trials 1,826 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, Not Recruiting

Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDG

NCT04892667

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Cardiology department Paris, France

View Trial Details

Active, Not Recruiting

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

NCT02790515

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +32 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

NCT02734771

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester, New York, United States

University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Active, Not Recruiting

Health Surveillance at University of Applied Science Hamburg (HAW)

NCT07089914

Conditions: Anxiety, Anxiety Acute, Anxiety Depression, +24 more
Locations: Hamburg University of Applied Sciences/Hochschule für Angewandte Wissenschaften Hamburg (HAW Hamburg) Hamburg, Germany

View Trial Details

Active, Not Recruiting

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

NCT03684889

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Children's Hospital Los Angeles Los Angeles, California, United States

Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Muscle Dysfunction in Patients With Haematological Diseases

NCT05150561

Conditions: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Active, Not Recruiting

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

NCT00923013

Conditions: Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, Not Recruiting

Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00379041

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Not specified

View Trial Details

Active, Not Recruiting

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

NCT00002462

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations: Algemeen Ziekenhuis Middelheim Antwerp, Belgium

A.Z. St. Jan Bruges, Belgium

Hopital Universitaire Erasme Brussels, Belgium

C.H.U. Saint-Pierre Brussels (Bruxelles), Belgium

View all 56 locations

View Trial Details

Active, Not Recruiting

Occurrence of Acute Kidney Injury After CAR-T Cells Treatments in B-cell Lymphoma.

NCT07101913

Conditions: Acute Kidney Injury, Acute Kidney Injury (AKI), B Cell Lymphoma, +18 more
Locations: Nephrology department, Centre hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions